Adalimumab or etanercept. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Sacroiliac Joint Joints Hand Bones Spine Synovial Membrane Skin Cells, Cultured

Organisms2

Mycobacterium tuberculosis Rats, Sprague-Dawley

Diseases55

Arthritis, Rheumatoid Arthritis, Psoriatic Spondylitis, Ankylosing Psoriasis Arthritis, Juvenile Spondylarthritis Uveitis, Anterior Crohn Disease Spondylarthropathies Hidradenitis Suppurativa Orbital Myositis Nevus, Sebaceous of Jadassohn Disease Progression Opportunistic Infections Wegener Granulomatosis Still's Disease, Adult-Onset Uveitis Pyoderma Gangrenosum Rheumatic Diseases Periostitis Intestinal Fistula Vasculitis, Central Nervous System Tuberculosis, Laryngeal Uveitis, Posterior Dermatitis, Exfoliative Fatigue Rheumatoid Vasculitis Labyrinth Diseases Lentigo Infection Meniere Disease Exanthema Synovitis Hepatitis, Alcoholic Chronic Disease Polymyalgia Rheumatica Inflammatory Bowel Diseases Hypergammaglobulinemia Pain Recurrence Glomerulosclerosis, Focal Segmental Arthritis, Experimental Drug Hypersensitivity Arthritis Disease Models, Animal Arthritis, Reactive Colitis, Ulcerative Sjogren's Syndrome Inflammation Autoimmune Diseases Acute Disease Hyperalgesia Neuralgia Sinusitis Nausea

Chemicals and Drugs46

Antirheumatic Agents Receptors, Tumor Necrosis Factor Antibodies, Monoclonal, Humanized Immunoglobulin G Antibodies, Monoclonal Tumor Necrosis Factor-alpha Methotrexate Anti-Inflammatory Agents Immunologic Factors Dermatologic Agents Anti-Inflammatory Agents, Non-Steroidal Immunosuppressive Agents Sulfasalazine Biological Products Placebos C-Reactive Protein Immunoconjugates Gastrointestinal Agents Hydroxychloroquine Receptors, Tumor Necrosis Factor, Type I Rheumatoid Factor Interleukin 1 Receptor Antagonist Protein Tumor Necrosis Factors Tight Junction Proteins Recombinant Fusion Proteins Antibodies, Monoclonal, Murine-Derived Azathioprine Immunoglobulin Fab Fragments Isoxazoles Prednisolone Tumor Necrosis Factor Decoy Receptors Prednisone Biological Markers Glucocorticoids Sialoglycoproteins Receptors, Tumor Necrosis Factor, Type II Adrenal Cortex Hormones Antibodies, Anti-Idiotypic Cytokines Methylprednisolone Antibodies Immunoglobulin D Antibodies, Antinuclear Interleukin-6 Gadolinium DTPA Cyclosporine

Analytical, Diagnostic and Therapeutic Techniques and Equipment53

Treatment Outcome Severity of Illness Index Drug Therapy, Combination Injections, Subcutaneous Double-Blind Method Drug Substitution Quality-Adjusted Life Years Remission Induction Blood Sedimentation Drug Administration Schedule Biological Therapy Product Surveillance, Postmarketing Disability Evaluation Treatment Failure Placebos Arthrography Randomized Controlled Trials as Topic Prospective Studies Models, Economic Clinical Trials, Phase IV as Topic Pilot Projects Follow-Up Studies Registries Symptom Assessment Retrospective Studies Cohort Studies Clinical Trials, Phase III as Topic Longitudinal Studies Administration, Cutaneous Retreatment Pain Measurement Clinical Trials as Topic Tuberculin Test Health Status Indicators Drug Monitoring Models, Econometric Sickness Impact Profile Arthritis, Experimental Magnetic Resonance Imaging Decision Support Techniques Drug Administration Routes Disease Models, Animal Withholding Treatment Adverse Drug Reaction Reporting Systems Colonoscopy Drug Evaluation Administration, Topical Questionnaires Islets of Langerhans Transplantation Statistics, Nonparametric Single-Blind Method Injections, Spinal Risk Factors

Psychiatry and Psychology4

Efficiency Trail Making Test Pain Pain Threshold

Phenomena and Processes8

Time Factors Dose-Response Relationship, Drug Drug Resistance Recovery of Function Pain Drug Tolerance Immunocompromised Host Pain Threshold

Disciplines and Occupations1

Gastroenterology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Health Status Cost of Illness

Humanities1

Quality of Life

Information Science6

Quality-Adjusted Life Years Registries Decision Support Techniques Adverse Drug Reaction Reporting Systems Questionnaires Databases, Factual

Health Care33

Treatment Outcome Severity of Illness Index Double-Blind Method Drug Substitution Quality-Adjusted Life Years Drug Costs Treatment Failure Cost-Benefit Analysis Randomized Controlled Trials as Topic Prospective Studies Models, Economic Clinical Trials, Phase IV as Topic Pilot Projects Health Status Follow-Up Studies Registries Retrospective Studies Cohort Studies Clinical Trials, Phase III as Topic Longitudinal Studies Health Care Costs Clinical Trials as Topic Health Status Indicators Models, Econometric Sickness Impact Profile Withholding Treatment Adverse Drug Reaction Reporting Systems Employment Questionnaires Statistics, Nonparametric Single-Blind Method Cost of Illness Risk Factors

Geographicals6

Great Britain United States Japan Sweden Canada Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care Geographicals

Antirheumatic Agents Receptors, Tumor Necrosis Factor Antibodies, Monoclonal, Humanized Immunoglobulin G Arthritis, Rheumatoid Arthritis, Psoriatic Spondylitis, Ankylosing Antibodies, Monoclonal Tumor Necrosis Factor-alpha Methotrexate Psoriasis Treatment Outcome Anti-Inflammatory Agents Arthritis, Juvenile Severity of Illness Index Immunologic Factors Drug Therapy, Combination Spondylarthritis Injections, Subcutaneous Dermatologic Agents Double-Blind Method Uveitis, Anterior Anti-Inflammatory Agents, Non-Steroidal Immunosuppressive Agents Sacroiliac Joint Joints Drug Substitution Crohn Disease Quality-Adjusted Life Years Spondylarthropathies Remission Induction Hidradenitis Suppurativa Sulfasalazine Drug Costs Blood Sedimentation Drug Administration Schedule Hand Bones Biological Therapy Product Surveillance, Postmarketing Biological Products Spine Disability Evaluation Treatment Failure Placebos Cost-Benefit Analysis Quality of Life Arthrography Orbital Myositis Randomized Controlled Trials as Topic C-Reactive Protein Nevus, Sebaceous of Jadassohn Immunoconjugates Disease Progression Opportunistic Infections Gastrointestinal Agents Efficiency Wegener Granulomatosis Hydroxychloroquine Still's Disease, Adult-Onset Prospective Studies Models, Economic Clinical Trials, Phase IV as Topic Uveitis Pyoderma Gangrenosum Pilot Projects Health Status Follow-Up Studies Time Factors Rheumatic Diseases Registries Receptors, Tumor Necrosis Factor, Type I Rheumatoid Factor Symptom Assessment Interleukin 1 Receptor Antagonist Protein Dose-Response Relationship, Drug Retrospective Studies Periostitis Intestinal Fistula Tumor Necrosis Factors Vasculitis, Central Nervous System Tuberculosis, Laryngeal Tight Junction Proteins Uveitis, Posterior Synovial Membrane Recombinant Fusion Proteins Cohort Studies Clinical Trials, Phase III as Topic Antibodies, Monoclonal, Murine-Derived Great Britain Drug Resistance Dermatitis, Exfoliative Longitudinal Studies Fatigue Rheumatoid Vasculitis Administration, Cutaneous Retreatment Health Care Costs Recovery of Function Labyrinth Diseases Azathioprine

No FAQ available that match "adalimumab or etanercept"